Company intelligence / Profile preview

Smith & Nephew

Watford, Hertfordshire, United Kingdomsmith-nephew.com ↗

Ownership: Public · SN
Employees: ~18000
Development stage: Other

Overview

Smith & Nephew markets a broad portfolio of commercialized medical devices and advanced wound care solutions globally. Their products are widely adopted in orthopaedics, sports medicine/ENT procedures, and complex wound management. The company continues to innovate with robotics-assisted surgery platforms and digital enabling technologies.

Therapeutic areas: OtherDermatologyRheumatology
Modalities: DeviceBiologic (for wound care products such as collagenase-based therapies)Small molecule (for certain wound care agents)
Industry: Surgical Medical Devices

Partnerships

Collaborations with hospitals/surgical centers worldwidepartnerships with academic institutions for clinical research are common but not always publicly detailed.

Financials

Market cap: $12.9B
Total revenue: $6.3B
Enterprise value: $15.9B

Beyond the preview

Go deeper on Smith & Nephew.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Smith & Nephew.